Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M. Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine. 2019;14:5541.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alzheimer’s Disease International (ADI), https://www.alzint.org/about/dementia-facts-figures/dementia-statistics/ (access on 24/1/2024).

Plascencia-Villa G, Perry G. Preventive and therapeutic strategies in Alzheimer’s disease: focus on oxidative stress, redox metals, and ferroptosis. Antioxid Redox Signal. 2021;34:591–610.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tatulian SA. Challenges and hopes for Alzheimer’s disease. Drug Discov Today. 2022;27:1027–43.

Article  PubMed  Google Scholar 

Athar T, Al Balushi K, Khan SA. Recent advances on drug development and emerging therapeutic agents for Alzheimer’s disease. Mol Biol Rep. 2021;48:5629–45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi R, Wu Q, Xin C, Yu H, Lim KL, Li X, et al. Structure-based specific detection and inhibition of monoamine oxidases and their applications in central nervous system diseases. Chembiochem. 2019;20:1487–97.

Article  CAS  PubMed  Google Scholar 

Bortolato M, Shih JC. Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. Int Rev Neurobiol. 2011;100:13–42.

Article  PubMed  PubMed Central  Google Scholar 

Xie SS, Liu J, Tang C, Pang C, Li Q, Qin Y, et al. Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer’s disease. Eur J Med Chem. 2020;202:112475.

Article  CAS  PubMed  Google Scholar 

Lu C, Zhou Q, Yan J, Du Z, Huang L, Li X, et al. A novel series of tacrine-selegiline hybrids with cholinesterase and monoamine oxidase inhibition activities for the treatment of Alzheimer’s disease. Eur J Med Chem. 2013;62:745–53.

Article  CAS  PubMed  Google Scholar 

Sies H. Role of metabolic H2O2 generation: redox signaling and oxidative stress. J Biol Chem. 2014;289:8735–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mertens MD, Hinz S, Müller CE, Gütschow M, et al. Alkynyl-coumarinyl ethers as MAO-B inhibitors. Bioorg Med Chem. 2014;22:1916–28.

Article  CAS  PubMed  Google Scholar 

Tripathi RKP, Ayyannan SR. Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: an overview and update. Med Res Rev. 2019;39:1603–706.

Article  CAS  PubMed  Google Scholar 

Thomas T. Monoamine oxidase-B inhibitors in the treatment of Alzheimer’s disease. Neurobiol Aging. 2000;21:343–8.

Article  CAS  PubMed  Google Scholar 

Chen GF, Xu TH, Yan Y, Zhou YR, Jiang Y, Melcher K, et al. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin. 2017;38:1205–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, et al. The amyloid-β pathway in Alzheimer’s disease. Mol Psychiatry. 2021;26:5481–503.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Q, Yu X, Li L, Zheng J, et al. Inhibition of amyloid-β aggregation in Alzheimer’s disease. Curr Pharm Des. 2014;20:1223–43.

Article  PubMed  Google Scholar 

Goyal D, Shuaib S, Mann S, Goyal B, et al. Rationally designed peptides and peptidomimetics as inhibitors of amyloid-β (Aβ) aggregation: potential therapeutics of Alzheimer’s disease. ACS Comb Sci. 2017;19:55–80.

Article  CAS  PubMed  Google Scholar 

Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, Maier M, et al. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature. 2016;537:50–6.

Article  CAS  PubMed  Google Scholar 

Albertini C, Salerno A, de Sena Murteira Pinheiro P, Bolognesi ML, et al. From combinations to multitarget-directed ligands: a continuum in Alzheimer’s disease polypharmacology. Med Res Rev. 2021;41:2606–33.

Article  PubMed  Google Scholar 

Ramalakshmi N, R SR, C NN. Multitarget directed ligand approaches for Alzheimer’s disease: a comprehensive review. Mini Rev Med Chem. 2021;21:2361–88.

Article  CAS  PubMed  Google Scholar 

Michalska P, Buendia I, Del Barrio L, Leon R, et al. Novel multitarget hybrid compounds for the treatment of Alzheimer’s disease. Curr Top Med Chem. 2017;17:1027–43.

Article  CAS  PubMed  Google Scholar 

Li JC, Zhang J, Rodrigues MC, Ding DJ, Longo JP, Azevedo RB, et al. Synthesis and evaluation of novel 1,2,3-triazole-based acetylcholinesterase inhibitors with neuroprotective activity. Bioorg Med Chem Lett. 2016;26:3881–5.

Article  CAS  PubMed  Google Scholar 

Zhang J, Li JC, Song JL, Cheng ZQ, Sun JZ, Jiang CS, et al. Synthesis and evaluation of coumarin/1,2,4-oxadiazole hybrids as selective BChE inhibitors with neuroprotective activity. J Asian Nat Prod Res. 2019;21:1090–103.

Article  CAS  PubMed  Google Scholar 

Jiang CS, Ge YX, Cheng ZQ, Wang YY, Tao HR, Zhu K, et al. Discovery of new selective butyrylcholinesterase (BChE) inhibitors with anti-Aβ aggregation activity: structure-based virtual screening, hit optimization and biological evaluation. Molecules. 2019;24:2568.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng ZQ, Zhu KK, Zhang J, Song JL, Muehlmann LA, Jiang CS, et al. Molecular-docking-guided design and synthesis of new IAA-tacrine hybrids as multifunctional AChE/BChE inhibitors. Bioorg Chem. 2019;83:277–88.

Article  CAS  PubMed  Google Scholar 

Cheng ZQ, Song JL, Zhu K, Zhang J, Jiang CS, Zhang H, et al. Total synthesis of pulmonarin B and design of brominated phenylacetic acid/tacrine hybrids: marine pharmacophore inspired discovery of new ChE and Aβ aggregation inhibitors. Mar Drugs. 2018;16:293.

Article  PubMed  PubMed Central  Google Scholar 

Jiang CS, Ge YX, Cheng ZQ, Song JL, Wang YY, Zhu K, et al. Discovery of new multifunctional selective acetylcholinesterase inhibitors: structure-based virtual screening and biological evaluation. J Comput Aided Mol Des. 2019;33:521–30.

Article  CAS  PubMed  Google Scholar 

Manzoor S, Hoda N. A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer’s disease agents: a review. Eur J Med Chem. 2020;206:112787.

Article  CAS  PubMed  Google Scholar 

Košak U, Strašek N, Knez D, Jukič M, Žakelj S, Zahirović A, et al. N-alkylpiperidine carbamates as potential anti-Alzheimer’s agents. Eur J Med Chem. 2020;197:112282.

Article  PubMed  Google Scholar 

Huang M, Xie SS, Jiang N, Lan JS, Kong LY, Wang XB. Multifunctional coumarin derivatives: monoamine oxidase B (MAO-B) inhibition, anti-β-amyloid (Aβ) aggregation and metal chelation properties against Alzheimer’s disease. Bioorg Med Chem Lett. 2015;25:508–13.

Article  CAS  PubMed  Google Scholar 

Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 2020;83:770–803.

Article  CAS  PubMed